nach oben

Diabetologia

Erschienen in:

01.10.2007 | Article

Oxidised, glycated LDL selectively influences tissue inhibitor of metalloproteinase-3 gene expression and protein production in human retinal capillary pericytes

verfasst von: J. L. Barth, Y. Yu, W. Song, K. Lu, A. Dashti, Y. Huang, W. S. Argraves, T. J. Lyons

Erschienen in: Diabetologia | Ausgabe 10/2007

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Matrix metalloproteinases (MMPs) and their natural inhibitors, tissue inhibitor of metalloproteinases (TIMPs), regulate important biological processes including the homeostasis of the extracellular matrix, proteolysis of cell surface proteins, proteinase zymogen activation, angiogenesis and inflammation. Studies have shown that their balance is altered in retinal microvascular tissues in diabetes. Since LDLs modified by oxidation/glycation are implicated in the pathogenesis of diabetic vascular complications, we examined the effects of modified LDL on the gene expression and protein production of MMPs and TIMPs in retinal pericytes.

Methods

Quiescent human retinal pericytes were exposed to native LDL (N-LDL), glycated LDL (G-LDL) and heavily oxidised and glycated LDL (HOG-LDL) for 24 h. We studied the expression of the genes encoding MMPs and TIMPs mRNAs by analysis of microarray data and quantitative PCR, and protein levels by immunoblotting and ELISA.

Results

Microarray analysis showed that MMP1, MMP2, MMP11, MMP14 and MMP25 and TIMP1, TIMP2, TIMP3 and TIMP4 were expressed in pericytes. Of these, only TIMP3 mRNA showed altered regulation, being expressed at significantly lower levels in response to HOG– vs N-LDL. Quantitative PCR and immunoblotting of cell/matrix proteins confirmed the reduction in TIMP3 mRNA and protein in response to HOG-LDL. In contrast to cellular TIMP3 protein, analysis of secreted TIMP1, TIMP2, MMP1 and collagenase activity indicated no changes in their production in response to modified LDL. Combined treatment with N– and HOG-LDL restored TIMP3 mRNA expression to a level comparable with that after N-LDL alone.

Conclusions/interpretation

Among the genes encoding for MMPs and TIMPs expressed in retinal pericytes, TIMP3 is uniquely regulated by HOG-LDL. Reduced TIMP3 expression might contribute to microvascular abnormalities in diabetic retinopathy.

Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827–839PubMedCrossRef

An E, Lu X, Flippin J et al (2006) Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors. J Proteome Res 5:2599–25610PubMedCrossRef

Plantner JJ, Jiang C, Smine A (1998) Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration. Exp Eye Res 67:637–645PubMedCrossRef

Weber BH, Vogt G, Pruett RC, Stohr H, Felbor U (1994) Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby’s fundus dystrophy. Nat Genet 8:352–356PubMedCrossRef

Grant MB, Caballero S, Tarnuzzer RW et al (1998) Matrix metalloproteinase expression in human retinal microvascular cells. Diabetes 47:1311–1317PubMedCrossRef

Das A, McGuire PG, Eriqat C et al (1999) Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes. Invest Ophthalmol Vis Sci 40:809–813PubMed

Giebel SJ, Menicucci G, McGuire PG, Das A (2005) Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab Invest 85:597–607PubMedCrossRef

Descamps FJ, Martens E, Kangave D et al (2006) The activated form of gelatinase B/matrix metalloproteinase-9 is associated with diabetic vitreous hemorrhage. Exp Eye Res 83:401–407PubMedCrossRef

Lyons TJ, Baynes JW, Patrick JS, Colwell JA, Lopes-Virella MF (1986) Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control. Diabetologia 29:685–689PubMedCrossRef

10.

Tsai EC, Hirsch IB, Brunzell JD, Chait A (1994) Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 43:1010–1014PubMedCrossRef

11.

Paniagua JA, Lopez-Miranda J, Perez-Martinez P et al (2005) Oxidized-LDL levels are changed during short-term serum glucose variations and lowered with statin treatment in early type 2 diabetes: a study of endothelial function and microalbuminuria. Diabet Med 22:1647–1656PubMedCrossRef

12.

Chisolm GM, Steinberg D (2000) The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 28:1815–1826PubMedCrossRef

13.

Song W, Barth JL, Lu K et al (2005) Effects of modified low-density lipoproteins on human retinal pericyte survival. Ann N Y Acad Sci 1043:1–6CrossRef

14.

Cusick M, Chew EY, Chan CC, Kruth HS, Murphy RP, Ferris FL III (2003) Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levels. Ophthalmology 110:2126–2133PubMedCrossRef

15.

Lyons TJ, Li W, Wells-Knecht MC, Jokl R (1994) Toxicity of mildly modified low-density lipoproteins to cultured retinal capillary endothelial cells and pericytes. Diabetes 43:1090–1095PubMedCrossRef

16.

Song W, Barth JL, Yu Y et al (2005) Effects of oxidized and glycated LDL on gene expression in human retinal capillary pericytes. Invest Ophthalmol Vis Sci 46:2974–2982PubMedCrossRef

17.

Li C, Wong WH (2001) Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98:31–36PubMedCrossRef

18.

Jenkins AJ, Velarde V, Klein RL et al (2000) Native and modified LDL activate extracellular signal-regulated kinases in mesangial cells. Diabetes 49:2160–2169PubMedCrossRef

19.

Vranka JA, Johnson E, Zhu X et al (1997) Discrete expression and distribution pattern of TIMP-3 in the human retina and choroid. Curr Eye Res 16:102–110PubMedCrossRef

20.

Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE (1996) Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 271:30375–30380PubMedCrossRef

21.

Huang Y, Mironava M, Lopes-Virella MF (1999) Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells. Arterioscler Thromb Vasc Biol 19:2640–2647PubMed

22.

Game BA, Maldonado A, He L, Huang Y (2005) Pioglitazone inhibits MMP-1 expression in vascular smooth muscle cells through a mitogen-activated protein kinase-independent mechanism. Atherosclerosis 2005 178:249–256CrossRef

23.

Lyons TJ, Jenkins AJ, Zheng D et al (2004) Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci 45:910–918PubMedCrossRef

24.

Jenkins AJ, Lyons TJ, Zheng D et al (2003) Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy. Kidney Int 64:817–828PubMedCrossRef

25.

van Leiden HA, Dekker JM, Moll AC et al (2002) Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn study. Diabetes Care 25:1320–1325PubMedCrossRef

26.

Misra A, Kumar S, Kishore Vikram N, Kumar A (2003) The role of lipids in the development of diabetic microvascular complications: implications for therapy. Am J Cardiovasc Drugs 3:325–338PubMedCrossRef

27.

Chen W, Jump DB, Grant MB, Esselman WJ, Busik JV (2003) Dyslipidemia, but not hyperglycemia, induces inflammatory adhesion molecules in human retinal vascular endothelial cells. Invest Ophthalmol Vis Sci 44:5016–5022PubMedCrossRef

28.

Barile GR, Pachydaki SI, Tari SR et al (2005) The RAGE axis in early diabetic retinopathy. Invest Ophthalmol Vis Sci 46:2916–2924PubMedCrossRef

29.

Lupo G, Anfuso CD, Ragusa N, Strosznajder RP, Walski M, Alberghina M (2001) t-Butyl hydroperoxide and oxidized low density lipoprotein enhance phospholipid hydrolysis in lipopolysaccharide-stimulated retinal pericytes. Biochim Biophys Acta 1531:143–155PubMed

30.

Qaum T, Xu Q, Joussen AM et al (2001) VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 42:2408–2413PubMed

31.

Smith EB, Staples EM (1982) Plasma protein concentrations in interstitial fluid from human aortas. Proc R Soc Lond B Biol Sci 217:59–75PubMedCrossRef

32.

Fedak PW, Altamentova SM, Weisel RD et al (2002) Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3. Am J Physiol Heart Circ Physiol 284:H626–H634PubMed

33.

Leeson TS (1979) Rat retinal blood vessels. Can J Ophthalmol 14:21–28PubMed

34.

Carlson EC (1989) Fenestrated subendothelial basement membranes in human retinal capillaries. Invest Ophthalmol Vis Sci 30:1923–1932PubMed

35.

Crocker DL, Murad TM, Geer JC (1970) Role of the pericyte in wound healing. An ultrastructural study. Exp Mol Pathol 13:90–94CrossRef

36.

Orlidge A, D’Amore PA (1987) Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol 105:1455–1462PubMedCrossRef

37.

Sato Y, Rifkin DB (1989) Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta-like molecule by plasmin during co-culture. J Cell Biol 109:309–315PubMedCrossRef

38.

Watanabe S, Morisaki N, Tezuka M et al (1997) Cultured retinal pericytes stimulate in vitro angiogenesis of endothelial cells through secretion of a fibroblast growth factor-like molecule. Atherosclerosis 130:101–107PubMedCrossRef

39.

Shepro D, Morel NM (1993) Pericyte physiology. FASEB J 7:1031–1038PubMed

40.

Hammes HP (2005) Pericytes and the pathogenesis of diabetic retinopathy. Horm Metab Res 37(Suppl 1):39–43PubMedCrossRef

41.

Kuwabara T, Cogan DG (1963) Retinal vascular patterns. VI. Mural cells of the retinal capillaries. Arch Ophthalmol 69:492–502PubMed

42.

Robison WG Jr, Nagata M, Tillis TN, Laver N, Kinoshita JH (1989) Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve. Invest Ophthalmol Vis Sci 30:2293–2299PubMed

43.

Saunders WB, Bohnsack BL, Faske JB (2006) Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3. J Cell Biol 175:179–191PubMedCrossRef

44.

Qi JH, Ebrahem Q, Moore N et al (2003) A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 9:407–415PubMedCrossRef

45.

Mohammed FF, Smookler DS, Taylor SE et al (2004) Abnormal TNF activity in Timp3−/− mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet 36:969–977PubMedCrossRef

46.

Joussen AM, Poulaki V, Le ML et al (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 18:1450–1452PubMed

47.

Federici M, Hribal ML, Menghini R et al (2005) Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. J Clin Invest 115:3494–3505PubMedCrossRef

48.

Federici M, Menghini R, Perego L et al (2006) Reduced TIMP3 levels in atherosclerotic plaques from patients affected by altered glucose tolerance. ADA Annual Scientific Sessions Abstracts, 657-P (Abstr)

49.

Fabunmi RP, Sukhova GK, Sugiyama S, Libby P (1998) Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells: a potential protective mechanism in plaque stability. Circ Res 83:270–278PubMed

Titel: Oxidised, glycated LDL selectively influences tissue inhibitor of metalloproteinase-3 gene expression and protein production in human retinal capillary pericytes
verfasst von: J. L. Barth
Y. Yu
W. Song
K. Lu
A. Dashti
Y. Huang
W. S. Argraves
T. J. Lyons
Publikationsdatum: 01.10.2007
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 10/2007
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-007-0768-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2007

Adiponectin levels do not predict clinical onset of type 1 diabetes in antibody-positive relatives

Anthropometry, carbohydrate and lipid metabolism in the East Flanders Prospective Twin Survey: heritabilities

Liver X receptor antagonist reduces lipid formation and increases glucose metabolism in myotubes from lean, obese and type 2 diabetic individuals

Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus

Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell line